Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Viale

Showing results (41-50 of 466) with videos related to

Pageof 47
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|September 6, 2023
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approachMilo Gatti, Sara Tedeschi, Eleonora Zamparini, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2020
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosingMilo Gatti, Maddalena Giannella, Emanuel Raschi, et al.
Infection and Drug Resistance|July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult PatientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Microorganisms|February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World EvidenceMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Therapeutic Drug Monitoring|February 2, 2023
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case StudyPier Giorgio Cojutti, Matteo Rinaldi, Maddalena Giannella, et al.
Expert Review of Anti-Infective Therapy|September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Expert Review of Anti-Infective Therapy|September 18, 2018
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosisMichele Bartoletti, Russell Edward Lewis, Maddalena Giannella, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2019
Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral SuspensionRussell E Lewis, Dimitrios P Kontoyiannis, Pierluigi Viale, et al.
Le Infezioni in Medicina|July 7, 2012
Myopericarditis during a primary Epstein-Barr virus infection in an otherwise healthy young adult. An unusual and insidious complication. Case report and a 60-year literature reviewSergio Sabbatani, Roberto Manfredi, Paolo Ortolani, et al.
Expert Review of Anti-Infective Therapy|March 17, 2019
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infectionMaddalena Giannella, Renato Pascale, Belén Gutiérrez-Gutiérrez, et al.
Pageof 47

Showing results (41-50 of 466) with videos related to

Sort By:
Pageof 47
Expert Opinion on Drug Metabolism & Toxicology|September 6, 2023
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approachMilo Gatti, Sara Tedeschi, Eleonora Zamparini, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2020
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosingMilo Gatti, Maddalena Giannella, Emanuel Raschi, et al.
Infection and Drug Resistance|July 8, 2021
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by <i>Enterobacterales</i> in Critically Ill Adult PatientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Microorganisms|February 25, 2023
Targeted Therapy of Severe Infections Caused by <i>Staphylococcus aureus</i> in Critically Ill Adult Patients: A Multidisciplinary Proposal of Therapeutic Algorithms Based on Real-World EvidenceMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Therapeutic Drug Monitoring|February 2, 2023
Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case StudyPier Giorgio Cojutti, Matteo Rinaldi, Maddalena Giannella, et al.
Expert Review of Anti-Infective Therapy|September 7, 2021
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patientsMilo Gatti, Bruno Viaggi, Gian Maria Rossolini, et al.
Expert Review of Anti-Infective Therapy|September 18, 2018
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosisMichele Bartoletti, Russell Edward Lewis, Maddalena Giannella, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2019
Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral SuspensionRussell E Lewis, Dimitrios P Kontoyiannis, Pierluigi Viale, et al.
Le Infezioni in Medicina|July 7, 2012
Myopericarditis during a primary Epstein-Barr virus infection in an otherwise healthy young adult. An unusual and insidious complication. Case report and a 60-year literature reviewSergio Sabbatani, Roberto Manfredi, Paolo Ortolani, et al.
Expert Review of Anti-Infective Therapy|March 17, 2019
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infectionMaddalena Giannella, Renato Pascale, Belén Gutiérrez-Gutiérrez, et al.
Pageof 47